novo nordisk cagrilintide shares plunge after CagriSema obesity drug trial disappoints Novo Nordisk's next-gen obesity drug

Pitavastatin and 4-hydroxy-3-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes

BPC-157 and TB-500 are the most common peptides that athletes are discussing

A better sleep plan may include therapy, medication review, nervous system support, trauma-informed treatment, circadian rhythm coaching, sleep apnea screening, or other evidence-based interventions

Preclinical studies have shown it may protect the gastric mucosa from damage caused by NSAIDs, alcohol, and other mucosal irritants

The extensive body of scientific research on BPC-157 underscores the need for high-purity material to conduct meaningful studies